摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol (S)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | 134028-03-8

中文名称
——
中文别名
——
英文名称
(1R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol (S)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
英文别名
——
(1R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol (S)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate化学式
CAS
134028-03-8
化学式
C16H16N2O6*C19H22N2O
mdl
——
分子量
626.709
InChiKey
YAUFSFSQDCKNRC-SMIJEWCMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.25
  • 重原子数:
    46.0
  • 可旋转键数:
    7.0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.34
  • 拓扑面积:
    155.13
  • 氢给体数:
    3.0
  • 氢受体数:
    9.0

反应信息

  • 作为反应物:
    描述:
    (1R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol (S)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate盐酸 作用下, 以 乙酸乙酯 为溶剂, 以84%的产率得到(S)-(+)-1,4-二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二甲酸单甲酯
    参考文献:
    名称:
    Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
    摘要:
    An efficient total synthesis of (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate in high optical purities is reported. The useful step is the resolution of racemic 2, 6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid by using commercially available Cinchona alkaloids cinchonidine and quinidine as the resolving agents. Under the optimum conditions, the optical purities for R- and S-enantiomers are extremely high (ee >99.5%). The further dihydropyridine receptor binding activity assay shows that the S-enantiomer is more potent than R- enantiomer both in rat cardiac (approximately 19 times) and cerebral cortex membrane (12 times). (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.12.104
  • 作为产物:
    描述:
    辛可尼丁2,6-二甲基-5-甲氧羰基-4-(3-硝基苯基)-1,4-二氢吡啶-3-羧酸N,N-二甲基甲酰胺 为溶剂, 反应 18.25h, 以41%的产率得到(1R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol (S)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
    参考文献:
    名称:
    Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
    摘要:
    An efficient total synthesis of (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate in high optical purities is reported. The useful step is the resolution of racemic 2, 6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid by using commercially available Cinchona alkaloids cinchonidine and quinidine as the resolving agents. Under the optimum conditions, the optical purities for R- and S-enantiomers are extremely high (ee >99.5%). The further dihydropyridine receptor binding activity assay shows that the S-enantiomer is more potent than R- enantiomer both in rat cardiac (approximately 19 times) and cerebral cortex membrane (12 times). (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.12.104
点击查看最新优质反应信息